Drug
Theanine
Theanine is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingearly_phase_1
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
NCT07220447
completednot_applicable
Theanine and Caffeine on Neurophysiology of Attention
NCT02770105
completednot_applicable
Anti-stress Effect of Theanine on Students During Long-term Pharmacy Practices
NCT01361204
Clinical Trials (3)
Showing 3 of 3 trials
NCT07220447Early Phase 1
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
NCT02770105Not Applicable
Theanine and Caffeine on Neurophysiology of Attention
NCT01361204Not Applicable
Anti-stress Effect of Theanine on Students During Long-term Pharmacy Practices
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3